LEADER 01664oam  2200433   450 
001 9910715951703321
005 20210413081100.0
024 8 $a43-503
035   $a(CKB)5470000002516578
035   $a(OCoLC)1245933837
035   $a(OCoLC)995470000002516578
035   $a(EXLCZ)995470000002516578
100   $a20210413d2021      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aInsider trading and stock option grants $ean examination of corporate integrity in the COVID-19 pandemic : hearing before the Subcommittee on Investor Protection, Entrepreneurship, and Capital Markets of the Committee on Financial Services, U.S. House of Representatives, One Hundred Sixteenth Congress, second session, September 17, 2020
210  1$aWashington :$cU.S. Government Publishing Office,$d2021.
215   $a1 online resource (v, 99 pages) $cillustrations
300   $aAccess ID (govinfo): CHRG-116hhrg43503.
300   $a"Serial no. 116-110."
320   $aIncludes bibliographical references.
517   $aInsider trading and stock option grants 
606   $aInsider trading in securities$zUnited States
606   $aStock options$zUnited States
606   $aCOVID-19 (Disease)$zUnited States
608   $aLegislative hearings.$2lcgft
615  0$aInsider trading in securities
615  0$aStock options
615  0$aCOVID-19 (Disease)
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910715951703321
996   $aInsider trading and stock option grants$93437278
997   $aUNINA